Is Alphabet Stock No Longer a Good Bet?
Alphabet tripled its price per share over the past 5…
Sell
42
NBY Quote, Financials, Valuation and Earnings
Last price:
$0.61
Seasonality move
:
-8.46%
Day range:
$0.61 - $0.65
52-week range:
$0.36 - $9.08
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.07x
P/B ratio:
2.89x
Volume:
75.9K
Avg. volume:
65.1K
1-year change:
-87.14%
Market cap:
$3.1M
Revenue:
$14.7M
EPS (TTM):
-$35.80
NBY Analysts' Consensus Rating
The 1 analyst providing 12-month price projections for NovaBay Pharmaceuticals shares anticipate an average target of $0.85, ranging from a low estimate of $0.85 to a high estimate of $0.85. This average target implies a growth of 34.92% compared to the current stock price of $0.63.
Consensus Price Target
$0.85
Highest Price Target
$0.85
Lowest Price Target
$0.85
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | -- | -- | Buy |
NBY Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Pepsi Vs Coke Stock: Which Is Best?
Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…
Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
52
RGC alert for Mar 19
Regencell Bioscience Holdings [RGC] is down 0.66% over the past day.
Sell
49
SRPT alert for Mar 19
Sarepta Therapeutics [SRPT] is up 8.72% over the past day.
Sell
46
CVNA alert for Mar 19
Carvana [CVNA] is up 5.74% over the past day.
